Objective: To compare the pharmacokinetic profile and bioavailability of budesonide after inhalation from the Clickhaler® dry powder inhaler with the Turbuhaler® as standard. Design: Randomised ...

In the present cohort study, the researchers compared the effectiveness and safety of two single-inhaler triple therapies for COPD — budesonide-glycopyrrolate-formoterol (administered twice ...

and colleagues compared the effectiveness and safety of budesonide-glycopyrrolate-formoterol, a twice-daily metered dose inhaler, and fluticasone-umeclidinium-vilanterol, a once-daily dry powder ...

Metered-dose inhaler budesonide-glycopyrrolate-formoterol (Breztri Aerosphere) was associated with a higher risk of a first moderate or severe COPD exacerbation (HR 1.09, 95% CI 1.04-1.14 ...

The upcoming release of Phase III Fasenra data in COPD in 2025 is expected to solidify AstraZeneca’s position in the market.

Whether inhaled corticosteroids (ICSs ... and an ‘MBBC-group’ (mometasone furoate, beclomethasone, budesonide or ciclesonide). The outcome was a MACE including ACS, ischaemic stroke, HF or CV-death, ...

Symbicort is a red inhaler that is a combination of budesonide and formoterol. There is no standard color code for inhalers and no laws or rulings requiring their use in the U.S. The color-coding ...

Objective To compare the effectiveness and safety of budesonide-glycopyrrolate-formoterol, a twice daily metered dose inhaler, and fluticasone-umeclidinium-vilanterol, a once daily dry powder inhaler, ...

The GoResp Digihaler – which delivers inhaled corticosteroid budesonide and long-acting beta agonist formoterol – has built-in sensors that detect and record data on a patient’s use and ...

William B. Feldman, M.D., M.P.H., from Brigham and Women’s Hospital in Boston, and colleagues compared the effectiveness and safety of budesonide-glycopyrrolate-formoterol, a twice-daily metered dose ...